Adia Med Inc. (ADIA) Stock

About Adia Med Inc.

Adia Med Inc. is a publicly traded company dedicated to advancing regenerative medicine and healthcare innovation. The company operates through its primary divisions: Adia Med clinics and Adia Labs LLC. Adia Med clinics deliver specialized regenerative treatments, including stem cell therapies, while Adia Labs manufactures and distributes regenerative products. The company is also involved in multiple Institutional Review Board (IRB)-approved clinical studies.

Adia Med Inc. is headquartered in US.

Adia Med Inc. (ADIA) stock trades at $0.12 with a market capitalization of $11.33M. The stock is valued at a price-to-earnings (P/E) ratio of -0.03, price-to-book of -0.04, price-to-sales of 16.17. Over the past 52 weeks the stock has ranged between $0.03 and $0.28, and currently trades 57.1% below its 52-week high.

On profitability, Adia Med Inc. generates a return on equity (ROE) of 306.95% — well above the market average, a sign of a high-quality business, return on capital employed of -81.51%, an operating margin of -52.32%, a net profit margin of -56.45%.

Official website: www.adianutrition.com